2009
DOI: 10.1016/j.bbrc.2009.06.052
|View full text |Cite
|
Sign up to set email alerts
|

All-trans retinoic acid-induced ADAM28 degrades proteoglycans in human chondrocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
8
0

Year Published

2010
2010
2020
2020

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 29 publications
0
8
0
Order By: Relevance
“…ADAM28 is a member of the ADAM (a disintegrin and metalloprotease domain) family. ADAM28 induced by all-trans retinoic acid can degrade both bovine and human proteoglycans in chondrocytes [25], which suggests that ADAM28 may be a new aggrecanase. Given that chondronecrosis in the deep zone of articular cartilage and growth plate cartilage is the key feature of KBD, ADAM28 may play a role in cartilage degradation of KBD patients.…”
Section: Discussionmentioning
confidence: 99%
“…ADAM28 is a member of the ADAM (a disintegrin and metalloprotease domain) family. ADAM28 induced by all-trans retinoic acid can degrade both bovine and human proteoglycans in chondrocytes [25], which suggests that ADAM28 may be a new aggrecanase. Given that chondronecrosis in the deep zone of articular cartilage and growth plate cartilage is the key feature of KBD, ADAM28 may play a role in cartilage degradation of KBD patients.…”
Section: Discussionmentioning
confidence: 99%
“…The enzyme has been suggested to promote retinoic acid-stimulated proteoglycan degradation 93 , although the molecular mechanism for this observation has not been established. Known substrates of ADAM28 include TNF 94 and growth factors such as IGF binding protein-3 95 and connective tissue growth factor (CTGF) 96 .…”
Section: Adamtssmentioning
confidence: 99%
“…ADAM-28, a membrane-bound protease, enhances chondrocytes releasing proteoglycan (Hikichi et al 2009). The activity of ADAM-28 is recently linked to the malignancy of chondrosarcoma (Matsuura et al 2010) and other cancers (Mochizuki and Okada 2009).…”
Section: Discussionmentioning
confidence: 98%